Literature DB >> 15122906

Quantitative analyses of bifunctional molecules.

Patrick D Braun1, Thomas J Wandless.   

Abstract

Small molecules can be discovered or engineered to bind tightly to biologically relevant proteins, and these molecules have proven to be powerful tools for both basic research and therapeutic applications. In many cases, detailed biophysical analyses of the intermolecular binding events are essential for improving the activity of the small molecules. These interactions can often be characterized as straightforward bimolecular binding events, and a variety of experimental and analytical techniques have been developed and refined to facilitate these analyses. Several investigators have recently synthesized heterodimeric molecules that are designed to bind simultaneously with two different proteins to form ternary complexes. These heterodimeric molecules often display compelling biological activity; however, they are difficult to characterize. The bimolecular interaction between one protein and the heterodimeric ligand (primary dissociation constant) can be determined by a number of methods. However, the interaction between that protein-ligand complex and the second protein (secondary dissociation constant) is more difficult to measure due to the noncovalent nature of the original protein-ligand complex. Consequently, these heterodimeric compounds are often characterized in terms of their activity, which is an experimentally dependent metric. We have developed a general quantitative mathematical model that can be used to measure both the primary (protein + ligand) and secondary (protein-ligand + protein) dissociation constants for heterodimeric small molecules. These values are largely independent of the experimental technique used and furthermore provide a direct measure of the thermodynamic stability of the ternary complexes that are formed. Fluorescence polarization and this model were used to characterize the heterodimeric molecule, SLFpYEEI, which binds to both FKBP12 and the Fyn SH2 domain, demonstrating that the model is useful for both predictive as well as ex post facto analytical applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122906     DOI: 10.1021/bi035839g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Analytical expressions for the homotropic binding of ligand to protein dimers and trimers.

Authors:  Scott T Lefurgy; Thomas S Leyh
Journal:  Anal Biochem       Date:  2011-12-16       Impact factor: 3.365

2.  A directed approach for engineering conditional protein stability using biologically silent small molecules.

Authors:  Lystranne A Maynard-Smith; Ling-Chun Chen; Laura A Banaszynski; A G Lisa Ooi; Thomas J Wandless
Journal:  J Biol Chem       Date:  2007-07-01       Impact factor: 5.157

3.  Exact analysis of ligand-induced dimerization of monomeric receptors.

Authors:  Eric T Mack; Raquel Perez-Castillejos; Zhigang Suo; George M Whitesides
Journal:  Anal Chem       Date:  2008-06-11       Impact factor: 6.986

4.  Creating diverse target-binding surfaces on FKBP12: synthesis and evaluation of a rapamycin analogue library.

Authors:  Xianghong Wu; Lisheng Wang; Yaohua Han; Nicholas Regan; Pui-Kai Li; Miguel A Villalona; Xiche Hu; Roger Briesewitz; Dehua Pei
Journal:  ACS Comb Sci       Date:  2011-07-28       Impact factor: 3.784

5.  A comprehensive mathematical model for three-body binding equilibria.

Authors:  Eugene F Douglass; Chad J Miller; Gerson Sparer; Harold Shapiro; David A Spiegel
Journal:  J Am Chem Soc       Date:  2013-04-16       Impact factor: 15.419

6.  Synthesis and analysis of stabilizing ligands for FKBP-derived destabilizing domains.

Authors:  Joshua S Grimley; Denise A Chen; Laura A Banaszynski; Thomas J Wandless
Journal:  Bioorg Med Chem Lett       Date:  2007-11-17       Impact factor: 2.823

Review 7.  Synthesis and biological evaluation of rapamycin-derived, next generation small molecules.

Authors:  Shiva Krishna Reddy Guduru; Prabhat Arya
Journal:  Medchemcomm       Date:  2017-11-22       Impact factor: 3.597

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.